Registration required for all attendees by September 8. Register Here.

Accepting abstracts for potential podium or poster presentation through August 7. 

View sponsorship opportunities.

Symposium Agenda

• 7:30 a.m.     Registration/Breakfast
• 8:20 a.m.     Opening Remarks and Welcome
• 8:30 a.m.     Session One - 5 speakers
• 10:10 a.m.   Break
• 10:40 a.m.   Session Two - 5 speakers
• 12:20 p.m.   Lunch
• 1:30 p.m.     Session Three - 4 speakers
• 2:50 p.m.     Break
• 3:10 p.m.     Keynote Lecture
• 4:30 p.m.     Poster Session and Networking Reception
• 6:30 p.m.     Adjourn

Complimentary registration required for all attendees. Registration is now closed

Rapid-fire and poster presentation submission deadline April 29

Registration (without abstract submission) is open through May 14.

Conference Agenda

• 8:00 a.m. -   Registration/Breakfast
• 9:00 a.m. -   Opening Remarks - Andrés García
• 9:15 a.m. -   Abigail Wojtowicz, Medical Director, US Medical Strategy, Takeda
• 10:00 a.m. - Tina Dorr, Partner, Barnes & Thornburg Law
• 10:30 a.m. - Poster Session
• 11:45 a.m. - Cherry Wan, Senior Manager, Chemical Science, Alcon
• 12:15 p.m. - Lunch
• 1:30 p.m. -   Bruno Marques, Senior Vice President, Technical Operations, Morphocell Technologies
• 2:15 p.m. -   Jianming Li, Senior Program Officer, Venture Well
• 2:45 p.m -    Break
• 3:05 p.m -    Rapid Fire Presentations (three minutes each)
• 4:00 p.m. -   Career Panel Discussion
• 5:00 p.m. -   Closing Remarks - Oliva Jones and Brendan Tobin
• 5:10 p.m. -   Reception and Award Ceremony
• 7:00 p.m. -   Adjourn

Rapid Fire Presenters

1. Maya Zhang - PI, Andrés García, "Developing an Intestine Organ Chip with Controlled Oxygen Gradients"
2. Aileen He - PI, Ahmet Coskun,"DYNAMICS: A Trajectory-based Framework for Inferring Non-contact, Cytokine-mediated Cell-cell Communication from Spatial Transcriptomics"
3. Aref Valipour - PI, Nick Housley, "Multiscale Microvascular Models"
4. Luiza DaMotta - PI, Andrés García, "Hydrogel-based Co-delivery of Antimicrobial Agents Eliminates Established Infection and Promotes Bone Healing"
5. Nisha Raman - PI, Mark Prausnitz, "Advancing Microneedle Technology for High Dose Delivery of Protein Therapeutics"
6. Athena Chien - PI, Craig Forest, "Membrane-resolved Epithelial electrophysiology revealed using extracellular electrochemical impedance spectroscopy (EEIS)"

Direct inquiries to connect@ibb.gatech.edu

Element Bio Workshop Registration | ibidi Workshop Registration

Agenda

• 8:00 a.m. Registration/Breakfast
• 8:30 a.m. Element Bio Workshop
• 10:00 a.m. Break/Networking
• 10:30 a.m. ibidi Workshop Part 1
• 11:15 a.m. ibidi Workshop Part 2
• 12:00 p.m. IBB Core Facilities Lab Tours
• 1:30 p.m. Adjourn (transit to GT-GLC)

Vendor Workshop Details 

• Element’s AVITI24™/VITARI™: A Multiomic NGS Platform for Deeper Insights and Higher Throughput
  In this session, Element will provide a technical overview of the AVITI platform family. AVITI delivers dependable, cost-effective NGS for foundational applications including gene expression profiling, single-cell sequencing, and targeted sequencing, with straightforward operation suited for shared cores and research labs. AVITI24 enables higher-resolution multiomic assays and Direct In Sample Sequencing, integrating spatial RNA, protein, and morphology readouts in a single run. Attendees will be introduced to VITARI, the world’s first high-throughput bench-top sequencer, designed for scalable performance and maximum flexibility.
• ibidi Part 1 - Free Partnership Offerings for Core Facilities and ibidi Overview
  This session includes a general review of ibidi products for live cell imaging, immunofluorescence, and 3D cell culture. Additionally, it will cover ibidi partnerships with Core Facilities.
• ibidi Part 2 - NEW Micro Illumination System – Benchtop Microfluidics and Microstructuring
  An informational session and live demo of the benchtop UV illumination device. The session will cover applications like 3D microstructuring, light-induced wound healing, micropatterning, hydrogel-structuring, and more. 

For details on the SEASR (Southeastern Association of Shared Resources) Conference at the Georgia Tech Learning Center on June 3-4, 2026, visit their conference page at https://seasr.abrf.org/.

Meetings are open to Members, Guests, Sponsors, Partners, and presenting Entrepreneurs from any of our Keiretsu Forum Global chapters and regions.

Due to SEC 506(c) regulations guests MUST pre-register to attend our meetings.

• Informative lectures from leading experts
• Hands-on training in small groups
• Proteomics and metabolomics applications
• Native mass spectrometry and UHMR
• HDX-MS and cross-linking MS
• Data analysis using multiple software platforms (e.g., MaxQuant, Compound Discoverer, Proteome Discoverer, etc.)

AGENDA OUTLINE
Oct. 7: 9 a.m. - 5 p.m.
Oct. 8: 9 a.m. - 5 p.m.
Oct. 9: 9 a.m. - 4:30 p.m.

Register HERE to participate virtually

Ashish Ranjan is an Endowed Professor in the Department of Radiation Oncology. He also serves as Vice Chair for Comparative Oncology and Research Innovation and Director of the Veterinary Research and Oncology Clinic. He earned his B.V.Sc. degree (DVM equivalent) from Madras Veterinary College, in Chennai, India, followed by a Ph.D. in biomedical and veterinary sciences from Virginia Tech. Ranjan was then a visiting fellow at the Center for Interventional Oncology, Department of Radiology and Imaging Sciences at the National Institutes of Health (NIH).

Ranjan's research interests are in the application of device-directed nanoparticles for solid tumor chemo-immunotherapy. His lab is actively engaged in preclinical and bench-to-bedside veterinary clinical trials and has received funding from several federal, state, and private sources. Ranjan has received several distinguished awards, including the NIH Merit Award. He also serves on the Scientific Advisory Board of Focused Ultrasound Foundation, UK's Humanimal Trust, and NIH panels.

Faculty host: Yue Chen

 

 "Learning Multicellular Rules From Spatial Perturbation Data to Construct Computational Non-Animal Models"

Peng Qiu
Professor, Wallace H. Coulter Distinguished Faculty Fellow
Wallace H. Coulter Department of Biomedical Engineering
Georgia Tech and Emory University

To attend via Zoom - register here.
Attend in-person at the Krone Engineered Biosystems Building (EBB), CHOA Seminar Room.

• Multi-Agent Multimodal RAG for Radiology Decision Support
• Robust Drug-Target Affinity for Precision Drug Discovery
• Safe Clinical Reasoning Agents for EHR-Based Diagnosis
• ICU Multi-Outcome Alarms for Critical Care Monitoring

Meetings are open to Members, Guests, Sponsors, Partners, and presenting Entrepreneurs from any of our Keiretsu Forum Global chapters and regions.

Due to SEC 506(c) regulations guests MUST pre-register to attend our meetings.

Meetings are open to Members, Guests, Sponsors, Partners, and presenting Entrepreneurs from any of our Keiretsu Forum Global chapters and regions.

Due to SEC 506(c) regulations guests MUST pre-register to attend our meetings.

Meetings are open to Members, Guests, Sponsors, Partners, and presenting Entrepreneurs from any of our Keiretsu Forum Global chapters and regions.

Due to SEC 506(c) regulations guests MUST pre-register to attend our meetings.

Meetings are open to Members, Guests, Sponsors, Partners, and presenting Entrepreneurs from any of our Keiretsu Forum Global chapters and regions.

Due to SEC 506(c) regulations guests MUST pre-register to attend our meetings.

Meetings are open to Members, Guests, Sponsors, Partners, and presenting Entrepreneurs from any of our Keiretsu Forum Global chapters and regions.

Due to SEC 506(c) regulations guests MUST pre-register to attend our meetings.

Meetings are open to Members, Guests, Sponsors, Partners, and presenting Entrepreneurs from any of our Keiretsu Forum Global chapters and regions.

Due to SEC 506(c) regulations guests MUST pre-register to attend our meetings.

Meetings are open to Members, Guests, Sponsors, Partners, and presenting Entrepreneurs from any of our Keiretsu Forum Global chapters and regions.

Due to SEC 506(c) regulations guests MUST pre-register to attend our meetings.

Meetings are open to Members, Guests, Sponsors, Partners, and presenting Entrepreneurs from any of our Keiretsu Forum Global chapters and regions.

Due to SEC 506(c) regulations guests MUST pre-register to attend our meetings.

Meetings are open to Members, Guests, Sponsors, Partners, and presenting Entrepreneurs from any of our Keiretsu Forum Global chapters and regions.

Due to SEC 506(c) regulations guests MUST pre-register to attend our meetings.

• Alex Adams - Interactive Computing - "Point-of-care Technologies for Fetal-maternal Health Monitoring"
• Ghassan AlRegib - Electrical and Computer Engineering - "Accessible Healthcare through AI-augmented Decisions (AHeAD)"
• Jon Duke - Computational Science and Engineering, Interactive Computing - "AI for Rural Health"
• Facundo Fernandez - Chemistry and Biochemistry - "AI-driven Metabolic Biomarker Discovery from High-dimensional Cellular Data"
• Ameet Pinto - Civil and Environmental Engineering - "AI-enabled Real-time Microbial Monitoring to Advance Sustainable Biomanufacturing"
• B. Aditya Prakash - Computational Science and Engineering - "AI for Epidemiology and Public Health"
• Agata Rozga - Interactive Computing - "Autism and Aging: Pushing AI Beyond Snapshots in Time"
• Nicoleta Serban - Industrial and Systems Engineering - "AI-enabled Operations Research for Health Systems"
• Jeffrey Skolnick - Biological Sciences - "Closing the Loop from Genome to Disease to Therapeutics to Patients with AI"
• May Dongmei Wang - Biomedical Engineering - "Translating AI for Impact in Healthcare: Challenges and Opportunities"
  
  Co-Chairs:
  Andrés García - Executive Director, Institute for Bioengineering and Bioscience
  David Sherrill - Executive Director, Institute for Data Science and Engineering
  May Dongmei Wang - Petit Faculty Fellow, Biomedical Engineering
   

Explore how expertise is evolving in the age of AI. Dr. Gichoya will share insights from four years of the HITI Lab Datathon, highlighting lessons on data science, training, and real-world applications of AI in healthcare.

BIO
Dr. Gichoya is the William and Kay Casarella Professor of Radiology at Emory University and leads the HITI (Healthcare AI Innovation and Translational Informatics) lab. Her work is centered around using data science to study health equity. Her group works in 4 areas - building diverse datasets for machine learning (for example the Emory Breast dataset); evaluating AI for bias and fairness; validating AI in the real world setting and training the next generation of data scientists (both clinical and technical students) through hive learning and village mentoring. She serves as the program director for radiology: AI trainee editorial board and the Emory University medical students machine learning elective. She has mentored over 60 students across the world (now successful faculty, post doc, PHD, and industry employees) from several institutions around the world. She has received several awards including the most influential radiology researcher in 2022 and is a 2023 Emerging Scholar at the National Academy of Medicine.

He is Professor of Bioengineering and Materials Science at UC Berkeley and Faculty Scientist at Lawrence Berkeley National Laboratory. He is a Fellow of the Royal Society of Chemistry, the American Institute for Medical and Biological Engineering, the Materials Research Society and the American Association for the Advancement of Science. In addition to his research, he mentors and teaches students in the fields of biomaterials design, materials science, polymer science, and nanomedicine.

Faculty host: Felipe Quiroz

 

Special emphasis is given to Tissue Engineering and Regenerative Medicine and particular applications and more details are described on the lab web page.

Faculty host: Alexander Vlahos

 

BIO
Jeffrey Hubbell is a pioneer in the field of immuno-modulatory materials whose research spans biology, chemistry, and engineering to generate novel solutions to common health problems. His work focuses on using biomaterials and engineered proteins to enhance the body’s own immune system to fight inflammatory and autoimmune disorders, allergies, and disease states like cancers. With more than 400 papers and 100 issued US patents, Hubbell uses biomaterials and protein engineering approaches to investigate topics in regenerative medicine and immunotherapeutics. In regenerative medicine, he develops both materials and protein therapeutics to address issues such as chronic wound healing in diabetes and bone repair after trauma. In immunotherapeutics, he pursues nanomaterials in vaccination for infectious disease and cancer as well as targeted therapy with RNA, protein-material conjugates for inverse vaccines to induce antigen-specific tolerance in autoimmunity and allergy, and in protein therapy to tip immune balances toward aggression in immuno-oncology and toward tolerance in inflammatory disease. His interests are both basic and translational, having founded or co-founded six biomedical companies based on his technology.

Before moving to New York University, Hubbell was at the University of Chicago in the Pritzker School of Molecular Engineering, where he helped build its strength in immunoengineering. Prior to that, he was on the faculty of the Swiss Federal Institute of Technology Lausanne (EPFL, where he served as founding Director of the Institute of Bioengineering and Dean of the School of Life Sciences), the Swiss Federal Institute of Technology Zurich (ETHZ) and University of Zurich, the California Institute of Technology, and the University of Texas in Austin. He was elected to the US National Academy of Engineering in 2010, the National Academy of Medicine in 2019, the American Academy of Arts and Sciences in 2021, and the National Academy of Sciences in 2023.

Zoom link for virtual participation

With over 25 years of experience in pharmaceutical, biotechnology, and medical device development, Barbara Solow is a recognized leader in non-dilutive funding strategy and healthcare innovation. As the founder of Concept to Market LLC, she has guided organizations ranging from startups to global contractors through product commercialization, regulatory strategy, and public-sector funding, leading programs valued at over $1 billion for U.S. government agencies and helping clients secure more than $3 billion in non-dilutive funding. In this session, Barbara will share how non-dilutive funding can be used to help start and grow a biotech company while minimizing the need for dilutive capital.

The Bench2Market funding series is created to provide commercialization guidance to the university research community.  Learn more at https://biolocity.gatech.edu/news-and-events/b2m-talks/. 

Seminar Speakers

REGISTER HERE to attend in-person.

REGISTER HERE to attend online.

Scott M. Bryant
Managing Partner
Hutchison Law

Scott is a managing partner of Hutchison, office manager of the firm’s Atlanta office, and co-chair of the firm’s Life Sciences practice. He represents life sciences and technology companies, venture capital funds and early stage investors, with a focus on venture capital and other equity and debt financings, licensing and technology transactions, mergers and acquisitions, corporate governance, securities, joint ventures and other complex transactions. Scott’s extensive legal experience and business background as a management consultant make him a key trusted advisor to C-suite executives and corporate boards of directors.

Thursday, April 16, 2026, 11:30 AM - 12:30 PM

Georgia Tech: Suddath Seminar Room 1128 - Institute for Bioengineering and Biosciences Building (IBB)

RSVP

Speakers include:

• Kenneth De Jesus, Ph.D., Associate, Biomechanics
• Regan Lawson, Ph.D., Senior Managing Scientist, Human Factors
• Susie Shepardson, Ph.D., Senior Scientist, Human Factors
• Stacy Ross, M.S. Associate, Vehicle Engineering
• Joseph Pearson, Ph.D., Senior Associate, Biomechanics

This event is designed for students eager to exmplore internship and co-op opportunities with a global biopharma leader.

Date: Thursday, April 9, 2026

Time: 11:15 AM - 12:15 PM

Register online

• The U.A. Whitaker Building is building 165 on our campus map.
• If you would like to park near our office, please find directions here.
   

• The U.A. Whitaker Building is building 165 on our campus map.
• If you would like to park near our office, please find directions here.
   

• The U.A. Whitaker Building is building 165 on our campus map.
• If you would like to park near our office, please find directions here.
   

• The U.A. Whitaker Building is building 165 on our campus map.
• If you would like to park near our office, please find directions here.

• The U.A. Whitaker Building is building 165 on our campus map.
• If you would like to park near our office, please find directions here.

• The U.A. Whitaker Building is building 165 on our campus map.
• If you would like to park near our office, please find directions here.
   

• The U.A. Whitaker Building is building 165 on our campus map.
• If you would like to park near our office, please find directions here.
   

• The U.A. Whitaker Building is building 165 on our campus map.
• If you would like to park near our office, please find directions here.
   

• The U.A. Whitaker Building is building 165 on our campus map.
• If you would like to park near our office, please find directions here.
   

• The U.A. Whitaker Building is building 165 on our campus map.
• If you would like to park near our office, please find directions here.

Lunch will be provided!

Please RSVP using the QR code on the flyer or by clicking this link: https://forms.office.com/Pages/ResponsePage.aspx?id=u5ghSHuuJUuLem1_Mvqgg9FuTBtRwhtLgOC_3aEkn-tUN1NRN0tWOVVDWjA2QzRFOU8zWEQ5VlJTVC4u&origin=QRCode

Allison Traylor
Assistant Professor
College of Behavioral, Social, and Health Sciences
Clemson University

Whether your team is starting a new project, working to establish new norms, or setting expectations for new members, a team charter can help your team lay the foundation for success. A team charter is a codified plan for how a team will manage teamwork activities. Team charters are evidence-based and are associated with improved team performance. This hands-on workshop will describe the benefits of team charters and provide the resources necessary to implement an effective charter in your team.

Team consult opportunity:

Our Team Science Skills presenters have graciously opened their schedules to provide a limited amount of attendees with direct feedback and guidance on their personal team issues. During a one-hour consulting session, attendees will be able to directly ask our experts questions and get personalized advice on how to effectively move their team forward.  Requesters must attend the full session and complete the post-evaluation survey to be eligible. 

This discussion will focus on the personal side of the journey of an academic engineering researcher turned entrepreneur - founding and building their first company, establishing their team, developing a FDA regulated product, establishing manufacturing, and highlighting many of the lessons learned a long the way. The discussion will continue with further reflection on what early-stage entrepreneurs coming out of academia could expect on their own journeys and how we can support each other in bringing incredible technologies into the world as commercialized products.

Register to attend via Zoom.

The Bench2Market funding series is created to provide commercialization guidance to the university research community.  Learn more at https://biolocity.gatech.edu/news-and-events/b2m-talks/. 

Join us for lunch to learn how to better leverage the incredible resources available via your IBB Core Facilities! Lunch provided for registered attendees. 

Register to attend 

 

Come learn what you need to know for this year’s ACME POCT project solicitation! And you will have the opportunity to talk with our service team experts.

Join faculty from across the Georgia CTSA for an energetic and dynamic virtual networking session!

Abstract

• Automated filtration and detection of Influenza A virus from clinical swab samples
• Direct isolation of cell-free DNA (cfDNA) from whole blood
• Size-selective extraction of extracellular vesicles across multiple size intervals
• Execution of high-sensitivity, multistep immunoassays

Biography 

Register to attend via Zoom.

The Bench2Market funding series is created to provide commercialization guidance to the university research community.  Learn more at https://biolocity.gatech.edu/news-and-events/b2m-talks/. 

Our systems pharmacology approach constructs multi-scale, hybrid computational models that describe host immune, pathogen and drug dynamics within an infected patient. In close collaborations with experimentalists, we integrate these computational models with multiple in vitro and in vivo datasets to: predict drug efficacy, optimize treatment, identify new drug targets, and inform future experiments; all in the context of complex host-pathogen-drug interactions.

Faculty host: Melissa Kemp

2025-2026 Bioengineering Seminar Schedule

As an alternative, for over two decades we have been implementing directed evolution – the iterative genetic diversification of the viral genome and functional selection for desired properties – to engineer highly optimized, next generation AAV variants for efficient and targeted delivery to any cell or tissue target.  We have genetically diversified AAV using a broad range of approaches, and the resulting large (~109) libraries are then functionally selected for substantially enhanced delivery in small and large animal models.  Furthermore, our vector engineering process has more recently been enhanced through next generation sequencing and machine learning.  The resulting variants have been effective in both animal models and in 6 human clinical trials to date, and results from both will be discussed.

RESEARCH
The Schaffer research group employs molecular and cellular engineering approaches to investigate biomedical problems. They are interested in the related areas of stem cell bioengineering, gene delivery systems, and molecular virology, with applications in regenerative medicine and tissue engineering. One their our major research aims is dedicated to understanding the biology and exploring the therapeutic potential of gene delivery, which serves as an effective means to control stem cells. Gene therapy can be defined as the introduction of genetic material to the cells of an individual for therapeutic benefit. A variety of approaches are under development to use gene therapy for treating cancer, AIDS, and a number of inherited genetic disorders. For example, gene therapy could be used to replace the genes hemophilia patients are missing, to bolster the immune system to recognize and combat tumors, or to inhibit the replication of HIV virus. However, significant progress must still be made before these developing strategies become therapeutic realities. One of the most formidable obstacles to gene therapy is how to efficiently deliver genes to a sufficient number of cells to yield a therapeutic effect. A number of gene delivery vehicles, or vectors, are in development, and most exploit or emulate the abilities many viruses have evolved to deliver their genes to cells as part of their life cycles. However, while viruses have developed numerous strategies to deliver genes over millions of years of evolution, the efficiency and safety of vehicles based upon recombinant viruses must still be further improved. The Schaffer lab has developed numerous high-throughput directed evolution approaches to engineer the properties of viral vehicles at the molecular level to enhance their abilities to deliver genes. These successful efforts are enhancing the abilities of several vectors to make them more effective at delivering gene “medicines.”

View Full 2025-2026 Bioengineering Seminar Series Schedule

Seminar Speakers/Abstracts

Adriana Blazeski, Ph.D.  (Kamm Lab, MIT)

Jiah Kim, Ph.D. (Belmont Lab, UIUC)

Anderson Cerqueira, Ph.D. (Panitch Lab, Georgia Tech)

REGISTER HERE

VIEW 2-day AGENDA

Meeting Objectives:

1. Highlight the Broader Landscape of Translational Impact - Showcase key collaborations and successful examples of translating science into policy and population health, with insights from other sectors.
2. Equip Attendees with Tools and Strategies to Enhance Impact - Share practical methods to evaluate, communicate, and embed impact using health and economic indicators
3. Strengthen Shared Capacity Across the CTSA Network - Foster collaboration by sharing effective strategies for planning, implementing, and disseminating impact-driven research

Translational Impacts Working Group Leadership
Krist Holmes, PhD, Northwestern University Clinical and Translational Sciences Institute 
Emmanuel Tetteh, MD, MPH Washington University in St. Louis

Register to attend via Zoom.

The Bench2Market funding series is created to provide commercialization guidance to the university research community. Learn more at https://biolocity.gatech.edu/news-and-events/b2m-talks/. 

Meetings are open to Members, Guests, Sponsors, Partners, and presenting Entrepreneurs from any of our Keiretsu Forum Global chapters and regions.

Due to SEC 506(c) regulations guests MUST pre-register to attend our meetings.

 Join on Teams to speak with an Office of Licensing representative!

Held the 2nd Tuesday of each month in IBB.

• Do you have a patentable invention and want to protect it?
• Interested in commercializing your research either through licensing to an existing company or a startup?
• Want to learn about the commercialization resources available for entrepreneurs?

Stop by the IP and Commercialization Office Hours in the IBB atrium and meet with experts from the Office of Technology Licensing and Quadrant-i. We are at your service!  

The Experts:

• Cynthia Sundell, Senior Director of Life Sciences and Quadrant-i Principal
• Harold Solomon, Quadrant-i Principal
• Kashmira Kulkarni, Licensing Associate Office of Technology Licensing

James Wang is a General Partner at Creative Ventures, an early-stage deep tech venture fund investing in AI, healthcare, synthetic biology, and industrial technology, and the author of What You Need to Know About AI. Before becoming an investor, he co-founded Lioness as CTO, developing biofeedback devices with physiological sensors and building ML pipelines on data from thousands of users— giving him firsthand experience with the unique challenges of bringing bio-hardware from bench to market. In this talk, James will share what the journey from founder to VC taught him about what separates deep tech startups that succeed from those that stall, how AI is reshaping what's possible for biology-driven companies, and practical advice for researchers thinking about commercializing their work and raising venture capital.

REGISTER HERE to attend in-person.
 

Presented by:
Alan Gould, Vice President, J.P. Morgan

The Bench2Market funding series is created to provide commercialization guidance to the university research community. Learn more.

Shawn Burke, Presenter

Establishing and maintaining a productive research team is a difficult challenge across all stages of an academic’s career. The science of good teamwork applies across an academic career: from incorporating graduate students and post-docs to your first research team to crossing-boundaries in the creation and maintenance of an interdisciplinary expert team. In conjunction with Georgia Clinical and Translational Science Alliance, we are offering a skill series to develop the skills necessary to build and maintain your research team by leveraging existing teams research. This workshop will focus on leadership within your team. Graduate students, post-docs, and all levels of academic faculty are all welcome to attend this workshop.

Team consult opportunity:

Our Team Science Skills presenters have graciously opened their schedules to provide a limited amount of attendees with direct feedback and guidance on their personal team issues. During a one-hour consulting session, attendees will be able to directly ask our experts questions and get personalized advice on how to effectively move their team forward.  Requesters must attend the full session and complete the post-evaluation survey to be eligible. 

Shannon Marlow
Associate Professor
Management
University of Texas, San Antonio

Establishing and maintaining a productive research team is a difficult challenge across all stages of an academic’s career. The science of good teamwork applies across an academic career: from incorporating graduate students and post-docs to your first research team to crossing-boundaries in the creation and maintenance of an interdisciplinary expert team. In conjunction with Georgia Clinical and Translational Science Alliance, we are offering a skill series to develop the skills necessary to build and maintain your research team by leveraging existing teams research. This workshop will focus on leadership within your team. Graduate students, post-docs, and all levels of academic faculty are all welcome to attend this workshop.

Team consult opportunity:

Our Team Science Skills presenters have graciously opened their schedules to provide a limited amount of attendees with direct feedback and guidance on their personal team issues. During a one-hour consulting session, attendees will be able to directly ask our experts questions and get personalized advice on how to effectively move their team forward.  Requesters must attend the full session and complete the post-evaluation survey to be eligible. 

This program is essential for any investor aiming to enhance their strategic approach to startup funding and to ensure beneficial outcomes for all parties involved.